Protein Discovery Rejuvenates Aging Cells
Researchers identify an RNA-processing factor that reverses cellular age while maintaining essential cell functions.
Updated on Oct. 20, 2026 in Life Sciences
Live Poll
Should scientists prioritize gene-based interventions designed to extend human lifespan?
Scientists have identified an RNA-splicing protein called SRSF1 that rejuvenates aging human skin cells and extends the lifespan of aged mice. The treatment restores cellular youth without triggering the loss of identity often seen in other rejuvenation methods.
Why it matters
This breakthrough provides a potential therapeutic target that avoids the risks of abnormal cell proliferation found in partial reprogramming strategies. By isolating SRSF1, researchers aim to safely reverse age-related biological decline.
The study utilized transcriptomic profiles from 146 genes across individuals aged one to 96 to train a machine learning model. In fibroblasts, SRSF1 treatment yielded a 25% increase in collagen production and a 30% reduction in reactive oxygen species.
The players
Wyss Institute
This research organization specializes in biologically inspired engineering and served as a primary site for the study.
CIC bioGUNE
Located in Spain, this research center collaborated on the study examining RNA-processing factors.
The details
Using an adeno-associated viral vector, researchers targeted SRSF1 expression in the liver of aged mice to mitigate frailty. The intervention correlated with an estimated 26-year age reversal in human fibroblasts and a 44% reduction in frailty progression among the test subjects.
Timeline
October 20, 2026: The findings were published in the journal Nature Aging.
The Big Picture
This discovery marks a departure from partial cellular reprogramming techniques, which have historically been hindered by risks of tumor-promoting effects and loss of cellular identity. By isolating SRSF1, the research provides a new theoretical framework for targeted aging intervention.
While currently limited to laboratory models, this research suggests a future path for treating age-related frailty through targeted protein regulation. Scientists are now prioritizing studies to determine if these results can be translated into safe human therapies.
The takeaway
This study demonstrates that targeting specific RNA-splicing proteins could be a viable strategy for age reversal. Further research is necessary to ensure that such treatments remain safe and do not trigger uncontrolled cell growth in humans.
Further reading
Learn more about the latest breakthroughs in the field of Life Sciences.
Source note: This article includes information reported by Drug Discovery News.
Live Poll
Should scientists prioritize gene-based interventions designed to extend human lifespan?
